Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder

NCT00746681 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Tolterodine & Pregabalin
DRUG: Tolterodine
DRUG: Placebo
DRUG: Tolterodine & Pregabalin
DRUG: Pregabalin

Sponsor

Pfizer